| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arch Therapeutics, Inc. | PRESIDENT AND CHIEF EXECUTIVE, Director | Common Stock | 6,862 | $1,887 | $0.2750 | 31 Aug 2023 | Direct |
| Arch Therapeutics, Inc. | PRESIDENT AND CHIEF EXECUTIVE, Director | Stock Option (right to buy) | 1,250,000 | 10 Nov 2022 | Direct | ||
| Arch Therapeutics, Inc. | PRESIDENT AND CHIEF EXECUTIVE, Director | Warrants (right to buy) | 13,724 | 31 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARTHQ | Arch Therapeutics, Inc. | 31 Aug 2023 | 2 | +$1,887 | 4 | PRESIDENT AND CHIEF EXECUTIVE, Director | 08 Sep 2023, 18:47 |
| ARTHQ | Arch Therapeutics, Inc. | 10 Nov 2022 | 1 | $0 | 4 | PRESIDENT AND CHIEF EXECUTIVE | 10 Nov 2022, 20:50 |
| ARTHQ | Arch Therapeutics, Inc. | 06 Jul 2022 | 3 | +$24,000 | 4 | PRESIDENT AND CHIEF EXECUTIVE | 08 Jul 2022, 16:55 |
| ARTHQ | Arch Therapeutics, Inc. | 27 Sep 2021 | 2 | $0 | 4 | President, CEO and Director, Director | 01 Oct 2021, 08:06 |